-
Mashup Score: 32022 Hematology Review Series - 2 year(s) ago
The ASH Hematology Review Series is designed for fellows preparing to take the internal medicine hematology certification exam or those desiring a comprehensive update of hematology standards of care. This series provides a review of hematology patterned after the American Board of Internal Medicine (ABIM) Certification Examination Blueprint.The 2022 ASH Hematology Review Series will air two to…
Source: academy.hematology.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Guidance for Use and dosing of Selinexor in Multiple Myeloma in 2021: Consensus From International Myeloma Foundation Expert Roundtable - 2 year(s) ago
Selinexor is a first in class selective inhibitor of nuclear export (SINE), blocks exportin 1 (XPO1), a protein transporter, that among other actions, shuttles cargo proteins such as tumor suppressor proteins (TSPs), the glucocorticoid receptor (GR), and oncoprotein messenger RNAs (mRNAs) across the nuclear membrane to cytoplasm. By blocking XPO1, selinexor facilitates nuclear preservation and…
Categories: Latest Headlines, ManniTweet-
RT @EagleMyeloma: Guidelines for use of a drug paid for by the maker of the drug. 😬 #mssm https://t.co/n28q9VnYu9
-
-
Mashup Score: 0
In our exclusive interview, Marc J. Braunstein, MD, PhD, provides perspective on data in the upfront and relapsed/refractory settings regarding the use of triplet and quadruplet regimens, novel agents, and cellular therapies.
Source: OncLiveCategories: Hem/Oncs, Latest HeadlinesTweet-
Did a recent podcast with @OncLive on #myeloma abstracts from the @ASCO 2020 Annual Meeting. #ASCO20 #mssm https://t.co/ZPwUUV0JkH
-
Learn about #mpnsm, #mssm, #amyloidosis, & more from Drs. @Ccostello7, @SriNagalla, & Rachid Baz at tonight's Hematology Review Series virtual sessions! Enroll now: https://t.co/kmISqAp7CN https://t.co/1e8gnYSJsU